April 2023 Newsletter
Breakthroughs in immunotherapy and the mRNA platform are helping to pave the way for a new era in therapeutic cancer vaccines.
Breakthroughs in immunotherapy and the mRNA platform are helping to pave the way for a new era in therapeutic cancer vaccines.
We are now Cencora PharmaLex
PharmaLex is now part of Cencora, a leading global healthcare company with a foundation in pharmaceutical distribution. In 2024 and beyond PharmaLex and all the companies in PharmaLex family will begin a journey to becoming Cencora as well. Cencora brings the companies and services together under one new name. The name will change, but the level of attention and service you receive remains the same.